|
1
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al:
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee: Heart disease and stroke statistics − 2013
update: A report from the American Heart Association. Circulation.
127:e6–e245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu M, Zhang P, Chen M, et al: Aging might
increase myocardial ischemia/reperfusion-induced apoptosis in
humans and rats. Age (Dordr). 34:621–632. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marczak J, Nowicki R, Kulbacka J and
Saczko J: Is remote ischaemic preconditioning of benefit to
patients undergoing cardiac surgery? Interact Cardiovasc Thorac
Surg. 14:634–639. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han S, Huang W, Liu Y, Pan S, Feng Z and
Li S: Does leukocyte-depleted blood cardioplegia reduce myocardial
reperfusion injury in cardiac surgery? A systematic review and
meta-analysis. Perfusion. 28:474–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Murry CE, Jennings RB and Reimer KA:
Preconditioning with ischemia: A delay of lethal cell injury in
ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yellon DM and Downey JM: Preconditioning
the myocardium: From cellular physiology to clinical cardiology.
Physiol Rev. 83:1113–1151. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qiu Y, Tang XL, Park SW, Sun JZ, Kalya A
and Bolli R: The early and late phases of ischemic preconditioning:
A comparative analysis of their effects on infarct size, myocardial
stunning and arrhythmias in conscious pigs undergoing a 40-minute
coronary occlusion. Circ Res. 80:730–742. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Xiao Z, Yao J, Zhao G, Fa X and
Niu J: Participation of protein kinase C in the activation of Nrf2
signaling by ischemic preconditioning in the isolated rabbit heart.
Mol Cell Biochem. 372:169–179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z and
Bolli R: Demonstration of an early and a late phase of ischemic
preconditioning in mice. Am J Physiol. 275:H1375–H1387.
1998.PubMed/NCBI
|
|
10
|
Bolli R: Cardioprotective function of
inducible nitric oxide synthase and role of nitric oxide in
myocardial ischemia and preconditioning: An overview of a decade of
research. J Mol Cell Cardiol. 33:1897–1918. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abete P, Cacciatore F, Testa G, DellaMorte
D, Galizia G, Ferrara N and Rengo F: Clinical application of
ischemic preconditioning in the elderly. Dose Response. 8:34–40.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dawson R Jr and Meldrum MJ: Norepinephrine
content in cardiovascular tissues from the aged Fischer 344 rat.
Gerontology. 38:185–191. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tani M, Honma Y, Hasegawa H and Tamaki K:
Direct activation of mitochondrial K (ATP) channels mimics
preconditioning but protein kinase C activation is less effective
in middle-aged rat hearts. Cardiovasc Res. 49:56–68. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sadigh B, Quintana M, Sylvén C, Berglund M
and Brodin LA: The ischemic preconditioning effect of adenosine in
patients with ischemic heart disease. Cardiovasc Ultrasound.
7:522009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McCully JD, Toyoda Y, Uematsu M, Stewart
RD and Levitsky S: Adenosine-enhanced ischemic preconditioning:
Adenosine receptor involvement during ischemia and reperfusion. Am
J Physiol Heart Circ Physiol. 280:H591–H602. 2001.PubMed/NCBI
|
|
16
|
Schulman D, Latchman DS and Yellon DM:
Effect of aging on the ability of preconditioning to protect rat
hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ
Physiol. 281:H1630–H1636. 2001.PubMed/NCBI
|
|
17
|
Boengler K, Schulz R and Heusch G: Loss of
cardioprotection with ageing. Cardiovasc Res. 83:247–261. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Langendorff O: Untersuchungen am
uberlebenden Saugethierherzen. Pflugers Archives fur die Gesamte
Physiologie des Menschen and der Tiere. 61:291–332. 1895.(In
German). View Article : Google Scholar
|
|
19
|
Suzuki Y, Yeung AC and Ikeno F: The
pre-clinical animal model in the translational research of
interventional cardiology. JACC Cardiovasc Interv. 2:373–383. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
SkrzypiecSpring M, Grotthus B, Szelag A
and Schulz R: Isolated heart perfusion according to
Langendorff-still viable in the new millennium. J Pharmacol Toxicol
Methods. 55:113–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chorro FJ, SuchBelenguer L and
López-Merino V: Animal models of cardiovascular disease. Rev Esp
Cardiol. 62:69–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bell RM, Mocanu MM and Yellon DM:
Retrograde heart perfusion: The Langendorff technique of isolated
heart perfusion. J Mol Cell Cardiol. 50:940–950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hancu G, Simon B, Kelemen H, Rusu A,
Mircia E and Gyeresi A: Thin layer chromatographic analysis of
Beta-lactam antibiotics. Adv Pharm Bull. 3:367–371. 2013.PubMed/NCBI
|
|
24
|
Kaneko M, Shintani Y, Narita T, et al:
Extracellular high mobility group box 1 plays a role in the effect
of bone marrow mononuclear cell transplantation for heart failure.
PLoS One. 8:e769082013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bertazzo S, Gentleman E, Cloyd KL, Chester
AH, Yacoub MH and Stevens MM: Nano-analytical electron microscopy
reveals fundamental insights into human cardiovascular tissue
calcification. Nat Mater. 12:576–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao R, Podesser BK and Lim CC: The
continuing evolution of the Langendorff and ejecting murine heart:
New advances in cardiac phenotyping. Am J Physiol Heart Circ
Physiol. 303:H156–H167. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fredholm BB, Abbracchio MP, Burnstock G,
et al: Nomenclature and classification of purinoceptors. Pharmacol
Rev. 46:143–156. 1994.PubMed/NCBI
|
|
28
|
VintenJohansen J, Thourani VH, Ronson RS,
et al: Broad-spectrum cardioprotection with adenosine. Ann Thorac
Surg. 68:1942–1948. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lasley RD, Keith BJ, Kristo G, Yoshimura Y
and Mentzer RM Jr: Delayed adenosine A1 receptor preconditioning in
rat myocardium is MAPK dependent but iNOS independent. Am J Physiol
Heart Circ Physiol. 289:H785–791. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tomai F, Crea F, Chiariello L and Gioffrè
PA: Ischemic preconditioning in humans: Models, mediators and
clinical relevance. Circulation. 100:559–563. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yun N, Kim SH and Lee SM: Differential
consequences of protein kinase C activation during early and late
hepatic ischemic preconditioning. J Physiol Sci. 62:199–209. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Naderi R, Imani A, Faghihi M and Moghimian
M: Phenylephrine induces early and late cardioprotection through
mitochondrial permeability transition pore in the isolated rat
heart. J Surg Res. 164:e37–e42. 2010. View Article : Google Scholar : PubMed/NCBI
|
